Identification of Immunogenic Neo-epitopes for the Development of Personalised Pancreatic Cancer Vaccines

NCT04379960 · clinicaltrials.gov ↗

COMPLETED

Status

192

Enrollment

OTHER

Sponsor class

Conditions

The Initial Aim of This Project is to Perform in Vitro Validation of Neoepitope Candidates Selected From Available Mutanome Data

Interventions

OTHER: Peptides

Sponsor

Queen Mary University of London